Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

214
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

287
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
287
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

281
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
281
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

175
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
175
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

382
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
382
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

72
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
72

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Individualized Therapy Guided by Drug Susceptibility Testing for Multidrug-Resistant Tuberculosis.

Open forum infectious diseases·2026
Same author

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Nature communications·2026
Same author

Global burden of drug-resistant tuberculosis in children: A systematic analysis for the Global Burden of Disease Study.

The European respiratory journal·2026
Same author

Genomic characterization of the emerging multidrug-resistant <i>Klebsiella pneumoniae</i> ST6668 clone in northern Italy, 2020-2025.

Microbiology spectrum·2026
Same author

Rising bedaquiline resistance: exploring potential causes and next steps.

The European respiratory journal·2026
Same author

Effect of anti-tuberculosis drugs on the pharmacokinetics and pharmacodynamics of novel antidiabetic drugs: A scoping review.

Pulmonology·2026
Same journal

A hypermetabolic pulmonary lesion in a patient with breast cancer.

Breathe (Sheffield, England)·2026
Same journal

Rigid bronchoscopy is the gold standard management of inhaled foreign bodies in children: myth or maxim?

Breathe (Sheffield, England)·2026
Same journal

The price of immune awakening: bridging knowledge gaps in checkpoint inhibitor-related pneumonitis in lung cancer.

Breathe (Sheffield, England)·2026
Same journal

Where are we with biomarkers in paediatric asthma in 2026?

Breathe (Sheffield, England)·2026
Same journal

Recurrent invasive fungal infection with locally advanced thymoma: diagnostic challenges in complex mediastinal disease.

Breathe (Sheffield, England)·2026
Same journal

Elevated <i>D</i> <sub>LCO</sub> and pulmonary function evolution during treatment in a patient with hyperleukocytosis and leukostasis.

Breathe (Sheffield, England)·2026
查看所有相关文章

相关实验视频

Updated: Jul 26, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

结核病:当前和以后的挑战

Raquel Villar-Hernández1,2,3, Arash Ghodousi4,3, Olha Konstantynovska5,3

  • 1Institut d'Investigació Germans Trias i Pujol, Barcelona, Spain.

Breathe (Sheffield, England)
|June 19, 2023
PubMed
概括
此摘要是机器生成的。

尽管结核病是可以预防和治愈的疾病,但它仍然是一个全球性卫生危机. 紧急,多部门行动和研究投资对于打击结核病和克服流行病和冲突带来的挫折至关重要.

更多相关视频

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K

相关实验视频

Last Updated: Jul 26, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K

科学领域:

  • 全球健康 全球健康
  • 传染性疾病 传染性疾病
  • 公共卫生政策 公共卫生政策

背景情况:

  • 结核病 (TB) 是全球主要的健康威胁,也是传染病死亡的第二大原因.
  • 减少结核病发病率和死亡率的进展缓慢,并受到COVID-19大流行病的阻碍.
  • 最近的全球冲突加剧了控制结核病负担的挑战.

研究的目的:

  • 为了强调结核病持续存在的全球威胁.
  • 为了强调最近全球事件对结核病控制工作的影响.
  • 倡导加强和创新的策略来结束结核病.

主要方法:

  • 本研究是对当前全球结核病状况的审查和分析.
  • 它综合了结核病发病率,死亡率和实现结核病终结战略目标的进展数据.
  • 它考察了诸如流行病和冲突等外部因素对结核病控制的影响.

主要成果:

  • 全球努力导致结核病发病率和死亡率缓慢下降.
  • 由于COVID-19的流行,结核病控制计划受到负面影响.
  • 持续的冲突对减少结核病的努力构成了进一步的威胁.
  • 目前,绝大多数终结结核病战略目标都走出了轨.

结论:

  • 结束结核病需要紧急,全球和多部门的承诺.
  • 在研究和创新的重大投资是必不可少的.
  • 公平和快速实施新战略对于恢复势头至关重要.